E. Paraskevas

Cancer is a Preventable Disease that Requires Major Lifestyle Changes

Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge

The multitude and diversity of environmental carcinogens

Coagulation Abnormalities in Patients Who Have Liver Disease

GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)

Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group

What is “quality of evidence” and why is it important to clinicians?

GRADE guidelines: 7. Rating the quality of evidence—inconsistency

Lifestyle-related factors and environmental agents causing cancer: An overview

Diagnosis, management, and treatment of hepatitis C: An update # † ‡

The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis

Cancer-associated cachexia

GRADE guidelines 6. Rating the quality of evidence—imprecision

Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation

Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients

Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event

IMMUNOLOGY OF MULTIPLE SCLEROSIS

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

Relationship Between Adherence to Hepatitis C Virus Therapy and Virologic Outcomes

Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.

The Relation of Infection With the Hepatitis B Agent to Primary Hepatic Carcinoma

Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer

Meta-analysis of flavonoids for the treatment of haemorrhoids

Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants

Prospective, randomized, controlled, observer-blinded trial of combined infrared photocoagulation and micronized purified flavonoid fraction versus each alone for the treatment of hemorrhoidal disease

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha‐2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients

Immune thrombocytopenic purpura in a patient treated with interferon alfacon‐1

A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1

Australia antigen (HBsAg) carriers in a Greek community. Studies of transaminase (SGPT) levels.

Measles antibodies and autoantibodies in autoimmune disorders.

Treatment of malignant colonic obstructions with metal stents and laser.